Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000030

COFO and Secretary sold 3,497 shares at $30.09 ($105,225)

  • COFO and Secretary acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schuth Alexander O. · COFO and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-13 Exercise or conversion : show line 1 in the form +25,000 $0.68 $17,000 524,902 I
2023-02-13 Sale : show line 2 in the form −3,497 $30.09 $105,225 528,691 I
Open-market sales · 3,497 sh · avg $30.09 · $105,225

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-13 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −25,000 195,078 D
Loading xslF345X03/wf-form4_167650569228111.xml…